TP53 and type 2 diabetes mellitus: Under HBP administration, the enriched DEGs included pathways such as the Hippo signaling pathway, TGF-beta signaling pathway, HIF-1 signaling pathway, p53 signaling pathway, and cGMP-PKG signaling pathway, which have also been reported in T2DM research [69,70,71,72,73].